Loading...

Genscript Biotech Corporation

1548.HKHKSE
Healthcare
Biotechnology
HK$16.24
HK$-0.72(-4.25%)

Genscript Biotech Corporation 1548.HK Peers

See (1548.HK) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1548.HKHK$16.24-4.25%34.9B-25.37-HK$0.64N/A
1801.HKHK$80.70-0.06%133.3B-1345.00-HK$0.06N/A
2269.HKHK$28.00+0.90%113.9B32.94HK$0.85N/A
1177.HKHK$5.53-2.81%98.9B50.27HK$0.11+0.54%
9926.HKHK$95.85+0.42%85.9B-145.23-HK$0.66N/A
1530.HKHK$23.30-0.43%54.9B25.05HK$0.93+1.07%
3759.HKHK$17.30+1.29%45.6B15.04HK$1.15+1.49%
9995.HKHK$53.55-7.11%37.2B-17.97-HK$2.98N/A
9688.HKHK$33.15-4.05%36.4B-16.41-HK$2.02N/A
1877.HKHK$25.65-10.47%35B-17.45-HK$1.47N/A
Showing 1 to 10 of 56 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1548.HK vs 1801.HK Comparison

1548.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1548.HK stands at 34.9B. In comparison, 1801.HK has a market cap of 133.3B. Regarding current trading prices, 1548.HK is priced at HK$16.24, while 1801.HK trades at HK$80.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1548.HK currently has a P/E ratio of -25.37, whereas 1801.HK's P/E ratio is -1345.00. In terms of profitability, 1548.HK's ROE is -0.06%, compared to 1801.HK's ROE of -0.01%. Regarding short-term risk, 1548.HK is more volatile compared to 1801.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 1548.HK.

Stock Price Comparison

Loading...

Frequently Asked Questions